Literature DB >> 10404983

Inheritance of frontotemporal dementia.

T W Chow1, B L Miller, V N Hayashi, D H Geschwind.   

Abstract

BACKGROUND: Previous studies of families with fronto-temporal dementia (FTD) support an autosomal dominant inheritance pattern, but most studies have described genetic transmission in individual families specifically selected for the presence of multiple affected individuals.
OBJECTIVE: To investigate the familial presentation and inheritance of FTD and related disorders among a large group of FTD index cases unselected for family history of dementia. DESIGN AND
SETTING: We interviewed family members and reviewed medical records and autopsy reports at a university hospital and a university-affiliated hospital to determine the frequency of familial FTD and the most likely mode of inheritance. Characteristic families with the disorder are described, along with the history, clinical findings, and neuroimaging results in affected members of these families. PATIENTS AND PARTICIPANTS: The 42 index cases of FTD had a mean age of onset of 56.1 years (range, 40-69 years). Of these patients, 21 (50%) were women. All but one of the patients were white. Participants included male and female spouses and children of the index cases. family member with an FTD spectrum disorder and were considered familial cases. The majority (17 [89%]) of familial FTD cases showed a pattern consistent with dominant inheritance. If depression is excluded, familial cases decrease from 19 (45%) to 17 (40%), of which 15 (88%) showed a dominant transmission pattern. The initial presentations in the nonindex familial cases varied but most frequently consisted of personality and behavioral changes that preceded cognitive impairment (19 [43%]), followed by psychiatric illness (14 [33%]), dementia without behavioral change (5 [11%]), amyotrophic lateral sclerosis (5 [11%]), and parkinsonism (2[5%]). Two of the affected nonindex cases had dual presenting diagnoses. The average age of onset was 56.1 years and did not differ significantly between familial and nonfamilial cases. Onset of FTD-related symptoms occurred after the age of 65 years in only 4(10%) of 42 index cases and 3 (5%) of 60 affected relatives.
CONCLUSIONS: Familial FTD is usually inherited in an autosomal dominant pattern. The initial onset is insidious, often consisting of mood and behavioral changes occurring in presenile years that are often erroneously attributed to other nonneurologic causes. Although the precise incidence of FTD in North America is not known, it is one of the most common presenile dementias.

Entities:  

Mesh:

Year:  1999        PMID: 10404983      PMCID: PMC5786271          DOI: 10.1001/archneur.56.7.817

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  33 in total

Review 1.  Non-Alzheimer degenerative dementias.

Authors:  J Lowe; M G Spillantini
Journal:  Brain Pathol       Date:  1998-04       Impact factor: 6.508

Review 2.  Genetics of Parkinson's disease.

Authors:  R L Nussbaum; M H Polymeropoulos
Journal:  Hum Mol Genet       Date:  1997       Impact factor: 6.150

Review 3.  Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

4.  A pedigree series for mapping disease genes in bipolar affective disorder: sampling, assessment, and analytic considerations.

Authors:  M Baron; J Endicott; B Lerer; J E Loth; J R Alexander; R Simon; L Sharpe; M Gibbon; D Hasin; B Lilliston
Journal:  Psychiatr Genet       Date:  1994       Impact factor: 2.458

5.  Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex.

Authors:  T Lynch; M Sano; K S Marder; K L Bell; N L Foster; R F Defendini; A A Sima; C Keohane; T G Nygaard; S Fahn
Journal:  Neurology       Date:  1994-10       Impact factor: 9.910

6.  Familial non-specific dementia maps to chromosome 3.

Authors:  J Brown; A Ashworth; S Gydesen; A Sorensen; M Rossor; J Hardy; J Collinge
Journal:  Hum Mol Genet       Date:  1995-09       Impact factor: 6.150

7.  Neuronal ultrastructural abnormalities in a patient with frontotemporal dementia and motor neuron disease.

Authors:  L Chang; M Cornford; B L Miller; H Itabashi; I Mena
Journal:  Dementia       Date:  1995 Jan-Feb

8.  Familial aggregation in frontotemporal dementia.

Authors:  M Stevens; C M van Duijn; W Kamphorst; P de Knijff; P Heutink; W A van Gool; P Scheltens; R Ravid; B A Oostra; M F Niermeijer; J C van Swieten
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

9.  Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21-22.

Authors:  C L Lendon; T Lynch; J Norton; D W McKeel; F Busfield; N Craddock; S Chakraverty; G Gopalakrishnan; S D Shears; W Grimmett; K C Wilhelmsen; L Hansen; J C Morris; A M Goate
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

10.  Hereditary dysphasic dementia and the Pick-Alzheimer spectrum.

Authors:  J C Morris; M Cole; B Q Banker; D Wright
Journal:  Ann Neurol       Date:  1984-10       Impact factor: 10.422

View more
  56 in total

1.  Functional genomic analyses identify pathways dysregulated by progranulin deficiency, implicating Wnt signaling.

Authors:  Ezra Y Rosen; Eric M Wexler; Revital Versano; Giovanni Coppola; Fuying Gao; Kellen D Winden; Michael C Oldham; Lauren Herl Martens; Ping Zhou; Robert V Farese; Daniel H Geschwind
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

Review 2.  Biomarkers to identify the pathological basis for frontotemporal lobar degeneration.

Authors:  Murray Grossman
Journal:  J Mol Neurosci       Date:  2011-07-22       Impact factor: 3.444

3.  Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study.

Authors:  E Gordon; J D Rohrer; L G Kim; R Omar; M N Rossor; N C Fox; J D Warren
Journal:  Neurology       Date:  2010-02-23       Impact factor: 9.910

Review 4.  Frontotemporal dementia.

Authors:  Erik D Roberson
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

5.  Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN.

Authors:  J L Whitwell; C R Jack; B F Boeve; M L Senjem; M Baker; R Rademakers; R J Ivnik; D S Knopman; Z K Wszolek; R C Petersen; K A Josephs
Journal:  Neurology       Date:  2009-03-03       Impact factor: 9.910

Review 6.  Clinical aspects of familial forms of frontotemporal dementia associated with parkinsonism.

Authors:  Shinsuke Fujioka; Zbigniew K Wszolek
Journal:  J Mol Neurosci       Date:  2011-06-08       Impact factor: 3.444

7.  Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.

Authors:  Emilia M Gatto; Ricardo F Allegri; Gustavo Da Prat; Patricio Chrem Mendez; David S Hanna; Michael O Dorschner; Ezequiel I Surace; Cyrus P Zabetian; Ignacio F Mata
Journal:  Neurobiol Aging       Date:  2017-02-10       Impact factor: 4.673

8.  Genetics and genetic counseling: recommendations for Alzheimer's disease, frontotemporal dementia, and Creutzfeldt-Jakob disease.

Authors:  Jennifer Williamson; Susan LaRusse
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

9.  Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations.

Authors:  J L Whitwell; C R Jack; B F Boeve; M L Senjem; M Baker; R J Ivnik; D S Knopman; Z K Wszolek; R C Petersen; R Rademakers; K A Josephs
Journal:  Neurology       Date:  2009-09-29       Impact factor: 9.910

10.  FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.

Authors:  Hazel Urwin; Keith A Josephs; Jonathan D Rohrer; Ian R Mackenzie; Manuela Neumann; Astrid Authier; Harro Seelaar; John C Van Swieten; Jeremy M Brown; Peter Johannsen; Jorgen E Nielsen; Ida E Holm; Dennis W Dickson; Rosa Rademakers; Neill R Graff-Radford; Joseph E Parisi; Ronald C Petersen; Kimmo J Hatanpaa; Charles L White; Myron F Weiner; Felix Geser; Vivianna M Van Deerlin; John Q Trojanowski; Bruce L Miller; William W Seeley; Julie van der Zee; Samir Kumar-Singh; Sebastiaan Engelborghs; Peter P De Deyn; Christine Van Broeckhoven; Eileen H Bigio; Han-Xiang Deng; Glenda M Halliday; Jillian J Kril; David G Munoz; David M Mann; Stuart M Pickering-Brown; Valerie Doodeman; Gary Adamson; Shabnam Ghazi-Noori; Elizabeth M C Fisher; Janice L Holton; Tamas Revesz; Martin N Rossor; John Collinge; Simon Mead; Adrian M Isaacs
Journal:  Acta Neuropathol       Date:  2010-05-20       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.